Latest insights on atopic dermatitis and prurigo nodularis

Access to this content is not permitted for healthcare professionals based in the UK and USA.

Back to Learning Zone

This content is intended for healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Canada, Chile, China, Colombia, Costa Rica, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Lebanon, Macau, Malaysia, The Netherlands, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, and UAE

Please confirm that you are a healthcare professional in one of those countries.


This activity has been sponsored by Sanofi and Regeneron Pharmaceuticals.
Sanofi and Regeneron Pharmaceuticals provided financial support and video content, and have had input into the detailed project scope. This activity is provided by Touch Medical Communications (TMC) for touchIMMUNOLOGY. Content is intended for scientific exchange purposes only.

Atopic Dermatitis, Dermatological Conditions View Time: 5 mins

touchMEETING HIGHLIGHTS Latest insights on atopic dermatitis and prurigo nodularis

Key updates from 2 cutting-edge expert symposia presented at WCD 2023

Watch Time: 01:32

The 25th World Congress of Dermatology welcomed healthcare professionals from all over the world to explore the latest scientific research in chronic inflammatory skin diseases.

Watch Time: 00:44

Dr Koh outlines how younger age at onset of AD is associated with more persistent disease

Watch Time: 02:35

Dr Tang explains that AD and PN can coexist in some patients. He goes on to outline that AD is associated with substantial patient burden and multiple atopic and non-atopic comorbidities, and that PD presents with distinct comorbidity phenotypes. Lastly, he discusses the key differences in the systemic diseases associated with PN and AD.

Leave Feedback
Overview & Learning Objectives

At WCD 2023, the Advent Medical Education Program hosted 2 cutting-edge expert symposia:

  • Atopic dermatitis in children: early intervention can reduce long-term disease impact
  • Shared and unique roles of IL-4 and IL-13 in atopic dermatitis and prurigo nodularis

Discover more and watch the full symposia at

Learning Objectives

After watching this activity, participants should be better able to:

  • Gain an understanding of the impact of persistent disease in atopic dermatitis from childhood to adulthood
  • Explore the relationship between age of onset of atopic dermatitis, increased disease persistence, and the development of other associated atopic conditions
  • Understand that atopic dermatitis and prurigo nodularis are two distinct dermatological diseases that can coexist in one patient and are associated with multiple atopic and non-atopic comorbidities
  • Differentiate the clinical features of both atopic dermatitis and prurigo nodularis while considering the common and distinct factors that impact their pathophysiology, presentation, and progression
Faculty & Disclosures
Dr Mark Koh

KK Women’s and Children’s Hospital, Singapore

Clinical Associate Professor Mark Koh is a dermatologist, paediatric dermatologist and dermatopathologist. He is head and senior consultant of Dermatology Service, KK Women’s & Children’s Hospital (KKH), as well as visiting consultant at Singapore General Hospital, Sengkang General Hospital and National Cancer Centre.

Dr Mark Koh discloses: Research funding from Abbvie, Amryt, Aslan, Bioderma, FarmaMondo, Galderma, Hyphens, and Lilly; Speaker and/or consulting fees from Abbvie, Bioderma, DKSH, Ego, Galderma, Good Pharma, GSK, Hyphens, LEO, Lion, L’Oreal/LaRoche Posay, Menarini, Novartis, Pfizer, Quoin, Sanofi, and Zuellig.

Dr Mark Tang

The Skin Specialists and Laser Clinic, Mount Alverina Hospital, Singapore

Dr Mark Tang is a fully accredited Consultant Dermatologist with more than 20 years of outstanding clinical practice. He is a well-respected and highly regarded dermatologist and is a key opinion leader in the areas of eczema, immune-mediated skin diseases, wound healing and skin cancers, including skin lymphomas. He is a much sought after invited speaker and faculty member in conferences, workshops advisory boards both locally and overseas.  His passion for patient care, research and teaching is evidenced by the numerous patient compliments and many awards he has received throughout his illustrious career.

Dr Mark Tang discloses: Speaker, advisory board member and/or investigator for Bioderma, GSK, Hyphens, LEO Pharma, Menarini, Regeneron, and Sanofi.


View and download resources from this activity to support your learning

Feedback Close

Please provide feedback for this touchMEETING HIGHLIGHTS on the following
(scale of 1-5 where 1=strongly disagree and 5=strongly agree):

* = Mandatory Field

Feedback Close
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72